2021 survey of Staphylococcus aureus bacteraemia in New Zealand
Please note: As of 1 July 2025, the New Zealand Institute for Public Health and Forensic Science (PHF Science) is the new name for the Institute of Environmental Science and Research (ESR). Research and reports published prior to this date may reference the organisation’s former name.
Summary
Staphylococcus aureus is a leading cause of both community-associated and hospital-associated bacteraemia in New Zealand and is a significant cause of morbidity and mortality in Aotearoa New Zealand. The aims of the ESR S. aureus bacteraemia (SAB) surveillance programme were to document rates of antimicrobial resistance, to better characterise the molecular epidemiology of isolates causing SAB, to examine variations in mortality rates and to examine variations in SAB rates according to place of onset, patient age, ethnicity, socioeconomic deprivation, risk factors and co-morbidities. Diagnostic laboratories were asked to refer all S. aureus from blood during the survey period, which ran between 2021 and 2023.